A New Era: Targeting Iron Deficiency to Improve Heart Failure Outcomes
A panel-style format of 3 clinician experts that will discuss current and emerging diagnostic approaches to support iron deficiency (ID) as a treatment target in heart failure (HF). The panel will engage in objective, non-judgmental discussion of 3 cases to demonstrate best practices in clinical assessment and diagnosis of ID, as well as its management in patients with HF, with the goal of improving patient outcomes. The activity will also focus on reviewing the clinical impact of intravenous iron therapy in both chronic and acute HF settings.
A New Era: Targeting Iron Deficiency to Improve Heart Failure Outcomes
Clinical CommentaryDive into the current and emerging diagnostic approaches to support iron deficiency (ID) as a treatment target for heart failure (HF) with a panel of experts. This activity features case discussions that demonstrate best practices in the clinical assessment and diagnosis of ID, as well as its management in patients with HF to improve awareness around “medical misses” for optimal patient outcomes. This learning opportunity will also focus on reviewing the clinical impact of intravenous iron therapy in both chronic and acute HF settings.
Faculty: Javed Butler, MD, MPH, MBA; Robert J. Mentz, MD; Ileana Piña MD, MPH, FAHA, FACC, FHFSA
Release Date:
Expiration Date: June 27, 2023
CME/CE is no longer available for this activity
